文献速递MDS 与骨髓增殖性肿瘤白血病

ASXL1突变建模揭示PRC1介导的异常组蛋白修饰导致p16Ink4a去抑制而引起造血受损

Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification.
PubMed 文献 · Leukemia · 2018-07-02

研究通过新构建的Asxl1G643fs敲入小鼠探讨ASXL1突变的生物学效应,发现Asxl1G643fs/+杂合小鼠出现再现人类低危骨髓增生异常综合征(MDS)的表型,部分小鼠经较长潜伏期后发生MDS/骨髓增殖性肿瘤样疾病。机制上,突变型ASXL1不能与BMI1相互作用,导致p16Ink4a启动子区H2AK119ub1减少、p16Ink4a去抑制,进而诱导细胞衰老。

要点

  • Asxl1G643fs/+小鼠再现人类低危MDS表型,部分经长潜伏期发生MDS/骨髓增殖性肿瘤样疾病
  • 突变型ASXL1不能与BMI1相互作用,p16Ink4a启动子区H2AK119ub1显著减少
  • p16Ink4a杂合缺失可恢复造血干细胞池并改善造血干/祖细胞凋亡增加

核心结论

  • Asxl1突变体与Bmi1蛋白相互作用丧失影响PRC1活性,异常组蛋白泛素化导致p16Ink4a去抑制并诱导细胞衰老,从而在Asxl1G643fs/+小鼠中产生低危MDS样表型。
  • 该模型为揭示ASXL1突变所致血液系统疾病的分子基础及开发治疗策略提供了有用平台。

研究设计与样本

  • 研究采用新构建的Asxl1G643fs敲入小鼠,研究突变型的生物学效应。

主要发现

  • Asxl1G643fs杂合(Asxl1G643fs/+)小鼠出现再现人类低危骨髓增生异常综合征(MDS)的表型,部分小鼠经较长潜伏期后发生MDS/骨髓增殖性肿瘤样疾病。
  • Asxl1G643fs/+造血干细胞(HSC)中p16Ink4a启动子区周围的H2AK119ub1水平显著降低。
  • 突变型ASXL1与野生型ASXL1蛋白不同,不具备与BMI1相互作用的能力。
  • p16Ink4a杂合的Asxl1G643fs/+小鼠恢复了HSC池,并改善了造血干/祖细胞中增加的凋亡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In spite of distinct clinical importance, the molecular mechanisms how Additional sex combs-like 1 (ASXL1) mutation contributes to the pathogenesis of premalignant conditions are largely unknown. Here, with newly generated knock-in mice, we investigated the biological effects of the mutant. Asxl1G643fs heterozygous (Asxl1G643fs/+) mice developed phenotypes recapitulating human low-risk myelodysplastic syndromes (MDS), and some of them developed MDS/myeloproliferative neoplasm-like disease after long latency. H2AK119ub1 level around the promoter region of p16Ink4a was significantly decreased in Asxl1G643fs/+ hematopoietic stem cells (HSC), suggesting perturbation of Bmi1-driven H2AK119ub1 histone modification by mutated Asxl1. The mutant form of ASXL1 had no ability to interact with BMI1 as opposed to wild-type ASXL1 protein. Restoration of HSC pool and amelioration of increased apoptosis in hematopoietic stem and progenitor cells were obtained from Asxl1G643fs/+ mice heterozygous for p16Ink4a. These results indicated that loss of protein interaction between Asxl1 mutant and Bmi1 affected the activity of PRC1, and subsequent derepression of p16Ink4a by aberrant histone ubiquitination could induce cellular senescence, resulting in low-risk MDS-like phenotypes in Asxl1G643fs/+ mice. This model provides a useful platform to unveil the molecular basis for hematological disorders induced by ASXL1 mutation and to develop therapeutic strategies for these patients.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Uni M, Masamoto Y, Sato T, et al. Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification. Leukemia. 2018. PMID: 29967380. doi:10.1038/s41375-018-0198-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。